Receptor Activator of Nuclear Factor-kappa B
"Receptor Activator of Nuclear Factor-kappa B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor necrosis factor receptor family member that is specific for RANK LIGAND and plays a role in bone homeostasis by regulating osteoclastogenesis. It is also expressed on DENDRITIC CELLS where it plays a role in regulating dendritic cell survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
| Descriptor ID |
D053246
|
| MeSH Number(s) |
D12.776.543.750.705.852.760.345
|
| Concept/Terms |
Receptor Activator of Nuclear Factor-kappa B- Receptor Activator of Nuclear Factor-kappa B
- Receptor Activator of Nuclear Factor kappa B
- Receptor Activator of NF-kappa B
- Receptor Activator of NF kappa B
- TRANCE-R
- TRANCE R
- TRANCE Receptor
- RANK Protein
- Receptor Activator of NF-kappaB
- Receptor Activator of NF kappaB
- NF-KappaB Receptor Activator
- Activator, NF-KappaB Receptor
- NF KappaB Receptor Activator
- Receptor Activator, NF-KappaB
- Receptors, Tumor Necrosis Factor, Member 11a
- Receptor Activator of Nuclear Factor-kappaB
- Receptor Activator of Nuclear Factor kappaB
- Tumor Necrosis Factor Receptor Superfamily, Member 11a
- NF-Kappa B Receptor Activator
- NF Kappa B Receptor Activator
- CD265 Antigen
- Antigen, CD265
- TNFRSF11A Protein
|
Below are MeSH descriptors whose meaning is more general than "Receptor Activator of Nuclear Factor-kappa B".
Below are MeSH descriptors whose meaning is more specific than "Receptor Activator of Nuclear Factor-kappa B".
This graph shows the total number of publications written about "Receptor Activator of Nuclear Factor-kappa B" by people in this website by year, and whether "Receptor Activator of Nuclear Factor-kappa B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 3 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptor Activator of Nuclear Factor-kappa B" by people in Profiles.
-
Controversies in the use of new bone-modifying therapies in multiple myeloma. Br J Haematol. 2021 Jun; 193(6):1034-1043.
-
Airway M Cells Arise in the Lower Airway Due to RANKL Signaling and Reside in the Bronchiolar Epithelium Associated With iBALT in Murine Models of Respiratory Disease. Front Immunol. 2019; 10:1323.
-
Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis. Crit Rev Oncol Hematol. 2019 May; 137:1-8.
-
RANK and RANK Ligand Expression in Parotid Gland Carcinomas. Appl Immunohistochem Mol Morphol. 2018 08; 26(7):478-482.
-
Redundant modulatory effects of proinflammatory cytokines in human osteoblastic cells in vitro. Clin Exp Rheumatol. 2018 Nov-Dec; 36(6):959-969.
-
Evaluation of cortical mandibular bone in patients with oral squamous cell carcinoma. Clin Oral Investig. 2018 Mar; 22(2):783-790.
-
Extracellular vesicles regulate the human osteoclastogenesis: divergent roles in discrete inflammatory arthropathies. Cell Mol Life Sci. 2017 10; 74(19):3599-3611.
-
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer. Oncotarget. 2017 Jan 17; 8(3):3811-3825.
-
Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats. J Mol Histol. 2016 Aug; 47(4):389-99.
-
Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma. Leuk Lymphoma. 2005 Dec; 46(12):1699-707.